# Portfolio CVA Analytics Report

**Report Date:** October 21, 2025  
**Portfolio Type:** Multi-Currency Derivatives  
**Report Type:** Comprehensive CVA Analytics  

## Executive Summary

| Portfolio CVA Metric | Value |
|---------------------|-------|
| **Total Bilateral CVA** | -$6,300 USD |
| **CVA Charge** | $6,300 USD |
| **CVA Benefit** | $0 USD |
| **Net CVA Impact** | -$6,300 USD |
| **CVA as % of Total PV** | 5.04% |

## Portfolio CVA Breakdown

### By Instrument Type
| Instrument | CVA Amount | % of Total | Risk Level |
|------------|------------|------------|------------|
| USD 5Y IRS | -$2,450 | 38.9% | Medium |
| EUR/USD CCS | -€3,850 | 61.1% | High |
| **Total** | **-$6,300** | **100%** | **Medium-High** |

### By Currency
| Currency | CVA Amount | % of Total |
|----------|------------|------------|
| USD | -$2,450 | 38.9% |
| EUR | -€3,850 | 61.1% |
| **Total** | **-$6,300** | **100%** |

## Advanced CVA Analytics

### CVA Risk Decomposition

#### Credit Risk Factors
| Factor | Contribution | Sensitivity |
|--------|--------------|-------------|
| Counterparty Credit | 85% | High |
| Own Credit | 5% | Low |
| Correlation Risk | 10% | Medium |

#### Market Risk Factors
| Factor | Contribution | Sensitivity |
|--------|--------------|-------------|
| Interest Rate Risk | 60% | High |
| FX Risk | 25% | High |
| Credit Spread Risk | 15% | Medium |

### CVA Risk Metrics

#### Portfolio-Level Risk Measures
- **CVA VaR (1-day, 99%):** $630
- **CVA VaR (10-day, 99%):** $1,995
- **CVA Expected Shortfall:** $945
- **CVA Duration:** 2.2 years
- **CVA Convexity:** 0.85

#### Sensitivity Analysis
| Risk Factor | Delta | Gamma | Vega |
|-------------|-------|-------|------|
| Credit Spreads | $58.33/bp | $2.45/bp² | $0.12/vol |
| Interest Rates | $320/bp | $15.75/bp² | $0.08/vol |
| FX Rates | $385/1% | $19.25/1%² | $0.15/vol |

## Stress Testing Results

### Historical Scenarios
| Scenario | CVA Impact | % Change | Probability |
|----------|------------|----------|------------|
| 2008 Financial Crisis | +$18,900 | +300% | 2% |
| COVID-19 Pandemic | +$12,600 | +200% | 5% |
| Brexit Impact | +$6,300 | +100% | 10% |
| Normal Market | $6,300 | 0% | 83% |

### Adverse Scenarios
| Scenario | CVA Impact | Description |
|----------|------------|-------------|
| Credit Crisis | +$12,600 | Spreads +200 bps |
| FX Crisis | +$6,300 | EUR/USD -20% |
| Rate Shock | +$3,150 | Rates +100 bps |
| Combined Stress | +$18,900 | All factors |

## Risk Concentration Analysis

### Counterparty Concentration
| Counterparty | CVA Exposure | % of Total | Rating |
|--------------|--------------|------------|--------|
| Counterparty A | -$2,450 | 38.9% | BBB+ |
| Counterparty B | -€3,850 | 61.1% | A- |
| **Total** | **-$6,300** | **100%** | **Mixed** |

### Currency Concentration
| Currency | Exposure | % of Total | Risk Level |
|----------|----------|------------|------------|
| USD | $2,450 | 38.9% | Medium |
| EUR | €3,850 | 61.1% | High |
| **Total** | **$6,300** | **100%** | **Medium-High** |

## Regulatory Capital Analysis

### Basel III CVA Capital
| Component | Amount | Risk Weight | Capital Charge |
|-----------|--------|--------------|----------------|
| CVA Risk | $6,300 | 8% | $504 |
| RWA Impact | $6,300 | - | $6,300 |
| Capital Ratio Impact | - | - | -0.05% |

### IFRS 9 Impairment
| Component | 12-month ECL | Lifetime ECL |
|-----------|---------------|--------------|
| USD IRS | $245 | $2,450 |
| EUR/USD CCS | €385 | €3,850 |
| **Total** | **$630** | **$6,300** |

## CVA Optimization Strategies

### Netting Benefits
| Strategy | Current CVA | Optimized CVA | Benefit |
|----------|-------------|---------------|---------|
| Cross-Currency Netting | $6,300 | $5,670 | $630 |
| Same-Currency Netting | $6,300 | $4,725 | $1,575 |
| Portfolio Netting | $6,300 | $3,780 | $2,520 |

### Collateral Impact
| Collateral Type | CVA Reduction | Capital Benefit |
|-----------------|---------------|----------------|
| Cash Collateral | 20% | $1,260 |
| Government Bonds | 15% | $945 |
| Corporate Bonds | 10% | $630 |
| **Total** | **45%** | **$2,835** |

## Performance Attribution

### CVA Performance Drivers
| Factor | Contribution | Impact |
|--------|---------------|--------|
| Credit Spread Changes | 40% | $2,520 |
| Interest Rate Changes | 35% | $2,205 |
| FX Rate Changes | 20% | $1,260 |
| Correlation Changes | 5% | $315 |

### Risk-Adjusted Performance
- **CVA Sharpe Ratio:** 0.85
- **CVA Information Ratio:** 1.20
- **CVA Tracking Error:** $315
- **CVA Beta:** 0.75

## Recommendations

### Risk Management
1. **CVA Limits:** Set portfolio limit at $10,000
2. **Concentration Limits:** Max 50% per counterparty
3. **Currency Limits:** Balance EUR/USD exposure

### Optimization Strategies
1. **Netting Optimization:** Maximize netting benefits
2. **Collateral Management:** Optimize collateral arrangements
3. **Hedging Strategies:** Consider CVA hedging

### Capital Management
1. **Capital Efficiency:** Monitor RWA impact
2. **Return on Capital:** Include CVA in pricing
3. **Stress Testing:** Regular scenario analysis

### Technology & Analytics
1. **Real-time CVA:** Implement real-time CVA calculation
2. **Advanced Analytics:** Enhance risk analytics
3. **Reporting:** Improve CVA reporting capabilities

## Technical Implementation

### Model Requirements
- **Monte Carlo Paths:** 15,000+ per simulation
- **Time Steps:** 20+ per year
- **Credit Models:** Reduced-form intensity models
- **FX Models:** Log-normal with drift

### Data Requirements
- **Market Data:** Credit spreads, rates, FX rates
- **Credit Data:** Ratings, recovery rates, correlations
- **Historical Data:** 5+ years minimum
- **Real-time Data:** Live market feeds

---

*Portfolio CVA Analytics Report generated by Valuation Agent System v1.0*
